The depletion of PRMT1 induced apoptosis in medulloblastoma cells [160], while treatment with PRMT5 inhibitor decreased tumor growth and increased survival in a SHH medulloblastoma mouse model [161]. Here, PRMT5 is linked to medulloblastoma.